Neurobiological Technologies Top Insiders
| NTIIDelisted Stock | USD 0.0001 0.00 0.00% |
Neurobiological Technologies employs about 4 people. The company is managed by 2 executives with a total tenure of roughly 30 years, averaging almost 15.0 years of service per executive, having 2.0 employees per reported executive. Assessment of Neurobiological Technologies' management performance can provide insight into the firm performance.
| John Stuppin Chairman Founder, Director, Chairman of Nominating and Corporate Governance Committee and Member of Special Committee |
Neurobiological |
Neurobiological Technologies Management Team Effectiveness
Neurobiological Technologies' management efficiency ratios could be used to measure how well Neurobiological Technologies manages its routine affairs as well as how well it operates its assets and liabilities.Neurobiological Technologies Workforce Comparison
Neurobiological Technologies is regarded second in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 323. Neurobiological Technologies claims roughly 4.0 in number of employees contributing just under 2% to equities under Health Care industry.
The company has Profit Margin (PM) of 0.74 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.77 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.77. Neurobiological Technologies Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Neurobiological Technologies insiders, such as employees or executives, is commonly permitted as long as it does not rely on Neurobiological Technologies' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Neurobiological Technologies insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Wasiewski Warren W over a year ago Neurobiological Technologies exotic insider transaction detected |
Neurobiological Technologies Notable Stakeholders
A Neurobiological Technologies stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Neurobiological Technologies often face trade-offs trying to please all of them. Neurobiological Technologies' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Neurobiological Technologies' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| John Stuppin | Founder, Director, Chairman of Nominating and Corporate Governance Committee and Member of Special Committee | Profile | |
| Stephen Ferruolo | Sec | Profile |
About Neurobiological Technologies Management Performance
The success or failure of an entity such as Neurobiological Technologies often depends on how effective the management is. Neurobiological Technologies management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Neurobiological management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Neurobiological management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. The company was founded in 1987 and is based in Emeryville, California. Neurobiological Technologies operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
Neurobiological Technologies Workforce Analysis
Traditionally, organizations such as Neurobiological Technologies use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Neurobiological Technologies within its industry.Neurobiological Technologies Manpower Efficiency
Return on Neurobiological Technologies Manpower
| Revenue Per Employee | 1.5M | |
| Revenue Per Executive | 3M | |
| Net Income Per Employee | 1.2M | |
| Net Income Per Executive | 2.5M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Neurobiological Stock
If you are still planning to invest in Neurobiological Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neurobiological Technologies' history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |